Blood-based biomarkers in gastric cancer peritoneal metastases: current evidence and potential clinical applications.

Kyrochristou GD, Kyrochristou ID, Papameti A, Fousekis FS, Rausei S, Vlachos K, Lianos GD

Open source

DOI
10.1080/17410541.2026.2754362
Published
2026 Oct 30
Container
Personalized medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17410541.2026.2754362,
  title = {Blood-based biomarkers in gastric cancer peritoneal metastases: current evidence and potential clinical applications.},
  author = {Kyrochristou GD and Kyrochristou ID and Papameti A and Fousekis FS and Rausei S and Vlachos K and Lianos GD},
  year = {2026},
  journal = {Personalized medicine},
  doi = {10.1080/17410541.2026.2754362},
  url = {https://doi.org/10.1080/17410541.2026.2754362}
}

RIS

TY  - JOUR
TI  - Blood-based biomarkers in gastric cancer peritoneal metastases: current evidence and potential clinical applications.
AU  - Kyrochristou GD
AU  - Kyrochristou ID
AU  - Papameti A
AU  - Fousekis FS
AU  - Rausei S
AU  - Vlachos K
AU  - Lianos GD
PY  - 2026
JO  - Personalized medicine
DO  - 10.1080/17410541.2026.2754362
UR  - https://doi.org/10.1080/17410541.2026.2754362
ER  - 

APA

GD, K., ID, K., A, P., FS, F., S, R., K, V., & GD, L. (2026). Blood-based biomarkers in gastric cancer peritoneal metastases: current evidence and potential clinical applications.. Personalized medicine. https://doi.org/10.1080/17410541.2026.2754362

Source records